No link between vitamin D levels at birth and early adulthood RA riskFebruary 24, 2022Rheumatoid Arthritis
Low disease activity tied to increased bone mineral density in RAFebruary 24, 2022Rheumatoid Arthritis
DMARDs or corticosteroids use may not explain reduced risk for Parkinson disease in RAFebruary 24, 2022Rheumatoid Arthritis
Early RA: Prevalence and factors associated with methotrexate-related adverse eventsFebruary 24, 2022Rheumatoid Arthritis
A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RAFebruary 24, 2022Rheumatoid Arthritis
Acute exacerbation affects prognosis in RA-associated interstitial lung diseaseFebruary 24, 2022Rheumatoid Arthritis
More evidence supporting ultra-low retreatment dose of rituximab in RAFebruary 24, 2022Rheumatoid Arthritis
Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitorsFebruary 24, 2022Rheumatoid Arthritis
Rheumatology NewsTreat-to-target in RA: Questions remain about adoption, measurementFebruary 22, 2022Rheumatoid Arthritis
Rheumatology NewsPatients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022COVID-19 UpdatesRheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsDietary recommendations for inflammatory rheumatic diseasesFebruary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Rheumatology NewsBoxed warning for JAK inhibitors belies their durability in real-world registry studiesFebruary 9, 2022Rheumatoid Arthritis
Rheumatology NewsLilly calls it quits on baricitinib’s development for lupusJanuary 28, 2022Lupus & Connective Tissue DiseasesRheumatoid Arthritis
